Christopher C. Caillouet

Array ( [id] => 443351 [patent_doc_number] => 07256288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-14 [patent_title] => 'Heteroaryl carboxylic acid amides' [patent_app_type] => utility [patent_app_number] => 10/496404 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7240 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256288.pdf [firstpage_image] =>[orig_patent_app_number] => 10496404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468906 [patent_doc_number] => 20040054009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => '(BIS)sulfonamide derivatives' [patent_app_type] => new [patent_app_number] => 10/275335 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60974 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20040054009.pdf [firstpage_image] =>[orig_patent_app_number] => 10275335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163271 [patent_doc_number] => 20050085457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Therapeutic quinolone compounds with 5-ht-antagonistic properties' [patent_app_type] => utility [patent_app_number] => 10/494196 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33421 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085457.pdf [firstpage_image] =>[orig_patent_app_number] => 10494196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918751 [patent_doc_number] => 20050096312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Therapeutic quinolone compounds with 5-ht-antagonistic properties' [patent_app_type] => utility [patent_app_number] => 10/494197 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33468 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096312.pdf [firstpage_image] =>[orig_patent_app_number] => 10494197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1148300 [patent_doc_number] => 06774237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-10 [patent_title] => 'Quinolinone derivatives' [patent_app_type] => B2 [patent_app_number] => 10/284017 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49567 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1550 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/774/06774237.pdf [firstpage_image] =>[orig_patent_app_number] => 10284017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1193454 [patent_doc_number] => 06730790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-04 [patent_title] => 'Chlorinated heterocyclic compounds and methods of synthesis' [patent_app_type] => B2 [patent_app_number] => 10/281684 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 10914 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730790.pdf [firstpage_image] =>[orig_patent_app_number] => 10281684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7436886 [patent_doc_number] => 20040002506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/281875 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18788 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002506.pdf [firstpage_image] =>[orig_patent_app_number] => 10281875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111757 [patent_doc_number] => 20050209213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Quinoline compound' [patent_app_type] => utility [patent_app_number] => 10/493427 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87566 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209213.pdf [firstpage_image] =>[orig_patent_app_number] => 10493427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002478 [patent_doc_number] => 06908932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Modulators of phosphoinositide 3-kinase' [patent_app_type] => utility [patent_app_number] => 10/280116 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5638 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908932.pdf [firstpage_image] =>[orig_patent_app_number] => 10280116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1182161 [patent_doc_number] => 06737530 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-18 [patent_title] => 'Process' [patent_app_type] => B2 [patent_app_number] => 10/258429 [patent_app_country] => US [patent_app_date] => 2002-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1303 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737530.pdf [firstpage_image] =>[orig_patent_app_number] => 10258429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711650 [patent_doc_number] => 20030171399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Quinolinyl and benzothiazolyl modulators' [patent_app_type] => new [patent_app_number] => 10/278851 [patent_app_country] => US [patent_app_date] => 2002-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43388 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171399.pdf [firstpage_image] =>[orig_patent_app_number] => 10278851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1206004 [patent_doc_number] => 06716857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-06 [patent_title] => 'Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors' [patent_app_type] => B2 [patent_app_number] => 10/273630 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10378 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716857.pdf [firstpage_image] =>[orig_patent_app_number] => 10273630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070186 [patent_doc_number] => 20050245571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Amine derivative' [patent_app_type] => utility [patent_app_number] => 10/492420 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37059 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245571.pdf [firstpage_image] =>[orig_patent_app_number] => 10492420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083884 [patent_doc_number] => 20050049264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors' [patent_app_type] => utility [patent_app_number] => 10/491898 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34923 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049264.pdf [firstpage_image] =>[orig_patent_app_number] => 10491898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216867 [patent_doc_number] => 20050054675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Interferon $g(g) production promoter' [patent_app_type] => utility [patent_app_number] => 10/494298 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3369 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054675.pdf [firstpage_image] =>[orig_patent_app_number] => 10494298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805450 [patent_doc_number] => 20030232844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2 mediated disorders' [patent_app_type] => new [patent_app_number] => 10/169443 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28036 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232844.pdf [firstpage_image] =>[orig_patent_app_number] => 10169443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7964083 [patent_doc_number] => 06680386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-20 [patent_title] => 'Process for preparing 2-(4-chlorobenzoylamino)-3-2 (1H)-quinolinon-4-yl propionic acid' [patent_app_type] => B2 [patent_app_number] => 10/240728 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3804 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680386.pdf [firstpage_image] =>[orig_patent_app_number] => 10240728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770458 [patent_doc_number] => 20030216398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Soluble beta amyloid precursor protein secretion promoters' [patent_app_type] => new [patent_app_number] => 10/240996 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34688 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216398.pdf [firstpage_image] =>[orig_patent_app_number] => 10240996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674816 [patent_doc_number] => 20030060419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers' [patent_app_type] => new [patent_app_number] => 10/254416 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10379 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060419.pdf [firstpage_image] =>[orig_patent_app_number] => 10254416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6640293 [patent_doc_number] => 20030212100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Quinoline derivatives and medicinal use thereof' [patent_app_type] => new [patent_app_number] => 10/239310 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23492 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212100.pdf [firstpage_image] =>[orig_patent_app_number] => 10239310 [rel_patent_id] =>[rel_patent_doc_number] =>)